Article Details
Retrieved on: 2022-01-13 16:14:28
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
2021 was a huge year for IPOs, with pure-play developers raising $14bn, but 2022 is likely to tell a different story. The pace of biopharma IPOs ...
Article found on: www.evaluate.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here